Longevity PapersAbout
← All papers
RESEARCH PAPER / 2026-02-24

S-nitrosoglutathione reductase GSNOR drives age-related obesity by promoting adipose tissue whitening through de-nitrosation of Beclin-1.

Xinhua Qiao, Ting Xie, Yuying Zhang, Chuanxin Sun, Xuanhao Wu, Yuzhe Chen, Qin Yao, Haoyang Shi, Shilong Li, Hongyu Zhao, Tiepeng Wang, Jiao Meng, Li Zhou, Mutian Niu, Yangxi Hu, Hansong Liu, Chang Chen

State Key Laboratory of Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, PR China. · pubmed

Abstract

Age-related obesity is a growing public health concern linked to various metabolic disorders, yet its underlying mechanisms remain incompletely understood. Here we report that S-nitrosoglutathione reductase (GSNOR), a pivotal denitrosation enzyme, increases in adipose tissue of both male mice and humans from middle-age. GSNOR knockout protects against age-related weight gain and enhances metabolism, whereas adipose-specific GSNOR knock-in mice promotes obesity and metabolic decline. Further investigation reveals that aged GSNOR KO mice maintain higher mitochondrial content and more beige adipocytes, whereas adipose-specific GSNOR overexpression promotes adipose tissue whitening. Mechanistically, GSNOR denitrosates Beclin-1 at cysteine 351 and mutation of this site (Beclin-1C351A) increases autophagy by enhancing Beclin-1 and ATG14 interaction, thereby accelerating beige-to-white adipocyte conversion. Together, our findings reveal that GSNOR regulates adipose tissue remodeling during aging through Beclin-1 S-nitrosation, pointing to a potential therapeutic target for age-related obesity.

The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.

Research summary

GSNOR regulates adipose tissue remodeling during aging through Beclin-1 S-nitrosation. The paper addresses a mechanism related to age-related obesity, which is a significant concern in the context of aging and metabolic health, suggesting potential therapeutic avenues for age-related conditions.

Author of this paper? Send a correction.